Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 187-193

  Bian, Yongqian ^a   Wang, Li ^b   Lu, Huanyu ^b   Yang, Guodong ^b   Zhang, Zhang ^a   Fu, Haiyan ^b   Lu, Xiaozhao ^b   Wei, Mengying ^b   Sun, Jianyong ^a   Zhao, Qingchuan ^a   Dong, Guanglong ^a,c   Lu, Zifan ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Gastric cancer; Methylation; Prognosis; RNA binding protein QKI

Indexed keywords

TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR QK1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; DISEASE SEVERITY; DISTANT METASTASIS; DNA METHYLATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE;

AGED; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84861458460     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.138     Document Type: Article

References (25)

1. Parkin D.M. Global cancer statistics in the year. Lancet Oncol. 2000, 2(2001):533-543.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
3. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991, 325:1132-1136.
4. Mbulaiteye S.M., Hisada M., El-Omar E.M. Helicobacter pylori associated global gastric cancer burden. Front. Biosci. 2009, 14:1490-1504.
5. Shibata D., Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 1992, 140:769-774.
6. Chang M.S., Lee H.S., Jung E.J., Kim C.W., Lee B.L., Kim W.H. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas. Int. J. Oncol. 2005, 27:1265-1272.
7. Howson C.P., Hiyama T., Wynder E.L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 1986, 8:1-27.
8. Larsson S.C., Giovannucci E., Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006, 131:1271-1283.
9. Cocco P., Ward M.H., Buiatti E. Occupational risk factors for gastric cancer: an overview. Epidemiol. Rev. 1996, 18:218-234.
10. Shin V.Y., Cho C.H. Nicotine and gastric cancer. Alcohol 2005, 35:259-264.
11. Biedermann B., Hotz H.R., Ciosk R. The Quaking family of RNA-binding proteins: coordinators of the cell cycle and differentiation. Cell Cycle 2010, 9:1929-1933.
12. Galarneau A., Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat. Struct. Mol. Biol. 2005, 12:691-698.
13. Yamamoto H., Soh J.W., Shirin H., Xing W.Q., Lim J.T., Yao Y., Slosberg E., Tomita N., Schieren I., Weinstein I.B. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 1999, 18:103-115.
14. Quaroni A., Tian J.Q., Seth P., Ap Rhys C. P27(Kip1) is an inducer of intestinal epithelial cell differentiation. Am. J. Physiol. Cell Physiol. 2000, 279:C1045-1057.
15. Deschenes C., Vezina A., Beaulieu J.F., Rivard N. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 2001, 120:423-438.
16. Yang G., Fu H., Zhang J., Lu X., Yu F., Jin L., Bai L., Huang B., Shen L., Feng Y., Yao L., Lu Z. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 2010, 138:231-240.
17. Yang G., Lu X., Wang L., Bian Y., Fu H., Wei M., Pu J., Jin L., Yao L., Lu Z. E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation. Cell Cycle 2011, 10:2703-2713.
18. Mulholland P.J., Fiegler H., Mazzanti C., Gorman P., Sasieni P., Adams J., Jones T.A., Babbage J.W., Vatcheva R., Ichimura K., East P., Poullikas C., Collins V.P., Carter N.P., Tomlinson I.P., Sheer D. Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme. Cell Cycle 2006, 5:783-791.
19. Ichimura K., Mungall A.J., Fiegler H., Pearson D.M., Dunham I., Carter N.P., Collins V.P. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 2006, 25:1261-1271.
20. Queimado L., Seruca R., Costa-Pereira A., Castedo S. Identification of two distinct regions of deletion at 6q in gastric carcinoma. Genes Chromosomes Cancer 1995, 14:28-34.
21. Li B.C., Chan W.Y., Li C.Y., Chow C., Ng E.K., Chung S.C. Allelic loss of chromosome 6q in gastric carcinoma. Diagn. Mol. Pathol. 2003, 12:193-200.
22. Chu D., Zhang Z., Li Y., Wu L., Zhang J., Wang W. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2. Mol. Cancer Ther. 2011, 10:47-56.
23. Yang L. Incidence and mortality of gastric cancer in China. World J. Gastroenterol. 2006, 12:17-20.
24. Cheung H.H., Lee T.L., Rennert O.M., Chan W.Y. DNA methylation of cancer genome. Birth Defects Res. C Embryo Today 2009, 87:335-350.
25. Li Z.Z., Kondo T., Murata T., Ebersole T.A., Nishi T., Tada K., Ushio Y., Yamamura K., Abe K. Expression of Hqk encoding a KH RNA binding protein is altered in human glioma. Jpn. J. Cancer Res. 2002, 93:167-177.